Short answer · Medically reviewed summary · Last updated: 2026-05-08
Familial Hypercholesterolemia (FH) is a genetic disorder characterized by dangerously high levels of low-density lipoprotein (LDL) cholesterol from birth. While commonly referred to as Familial Hypercholesterolemia, it is also clinically known as Type IIa Hyperlipoproteinemia or familial hypercholesterolemic xanthomatosis in older medical literature. What are the common synonyms and historical names for Familial Hypercholesterolemia? The medical community primarily uses the term Familial Hypercholesterolemia to ensure clear communication.
Familial Hypercholesterolemia (FH) is a genetic disorder characterized by dangerously high levels of low-density lipoprotein (LDL) cholesterol from birth. While commonly referred to as Familial Hypercholesterolemia, it is also clinically known as Type IIa Hyperlipoproteinemia or familial hypercholesterolemic xanthomatosis in older medical literature.
The medical community primarily uses the term Familial Hypercholesterolemia to ensure clear communication. However, patients may encounter various terms in medical records or legacy research papers. Historical names often reflect the clinical manifestations observed before the genetic basis was fully understood, such as "familial hypercholesterolemic xanthomatosis." In older classification systems, you may see it referred to as Type IIa Hyperlipoproteinemia based on the Fredrickson classification of lipid disorders.
To navigate medical records and research, it is helpful to know the official coding used by international health organizations. These identifiers help standardize the diagnosis of Familial Hypercholesterolemia across global healthcare systems:
The variation in naming for Familial Hypercholesterolemia stems from the evolution of medical science. Early descriptions were based on phenotypic observations, such as the presence of xanthomas (fatty deposits under the skin), leading to descriptive names. As our understanding of the genetic mutations—most commonly in the LDLR, APOB, or PCSK9 genes—advanced, the nomenclature shifted toward the specific underlying metabolic defect. Today, Familial Hypercholesterolemia is the universally preferred term, as it accurately captures both the hereditary nature and the primary biochemical presentation of the condition.
Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician with any questions regarding a medical condition.